UPDATE: New South Wales has intensified its battle against illegal tobacco shops, launching an urgent crackdown that involves a dedicated unit of 48 compliance...
Authorities in Australia are investigating a significant increase in adverse event reports associated with the ADHD medication Vyvanse. The Therapeutic Goods Administration (TGA) has...
Reports of adverse events linked to the ADHD medication Vyvanse have surged dramatically in Australia this year, prompting an investigation by the Therapeutic Goods...
Australia has reached a significant milestone in mental health treatment with the commencement of domestic MDMA production. Melbourne-based manufacturer Cortexa has successfully completed its...
In 2024, Australia’s Therapeutic Goods Administration (TGA) approved at least 979,000 applications for medicinal cannabis prescriptions through its specialised access pathways. Initially designed for...